Skip to main content
SpringerLink
Log in

Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Olfactomedin 4 (OLFM4) has been demonstrated to be upregulated in various cancers and involved in many cellular processes such as cell adhesion, apoptosis, and cell proliferation. In gastric cancer, clinicopathological relevance of OLFM4 expression has been reported. However, there are few studies showing how expression of OLFM4 evolves during multistep gastric carcinogenesis. In this study, we investigated OLFM4 expression during gastric carcinogenesis using RNA in situ hybridization (ISH). We found that OLFM4 expression is absent in normal gastric mucosa, begins to appear at the isthmus region in gastric glands in chronic gastritis, and is remarkably increased in intestinal metaplasia (IM). Interestingly, gastric-type glands around IM frequently expressed OLFM4 before CDX2 was expressed, suggesting that OLFM4 might be involved in regulating CDX2 expression. However, overexpression of OLFM4 failed to induce CDX2 transcription. All gastric adenomas were strongly positive for OLFM4. OLFM4 expression was higher in intestinal type, well to moderately differentiated and early-stage adenocarcinomas, and decreased in poorly differentiated and advanced-stage gastric cancer (GC). Although OLFM4 expression had no prognostic value for GC overall (P = 0.441), it was associated with poor survival of GC in stage II, III, and IV (P = 0.018), suggesting that OLFM4 expression has prognostic significance for late-stage GC. Our findings suggest that OLFM4 is not only involved in early stages of gastric carcinogenesis but also a useful prognostic marker for advanced GC, which is encouraging for further studies exploring OLFM4 as a potential target for therapy of GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Zhang J, Liu W-L, Tang DC, Chen L, Wang M, et al. (2002) Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 283:83–93

    Article  CAS  PubMed  Google Scholar 

  2. Chin KL, Aerbajinai W, Zhu J, Drew L, Chen L, et al. (2008) The regulation of OLFM4 expression in myeloid precursor cells relies on NF‐κB transcription factor. Br J Haematol 143:421–432

    Article  CAS  PubMed  Google Scholar 

  3. Kim KK, Park KS, Song SB, Kim KE (2010) Up regulation of GW112 gene by NFκB promotes an antiapoptotic property in gastric cancer cells. Mol Carcinog 49:259–270

    CAS  PubMed  Google Scholar 

  4. Liu W, Yan M, Liu Y, Wang R, Li C, et al. (2010) Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection. Proc Natl Acad Sci 107:11056–11061

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Lee HJ, Nam KT, Park HS, Kim MA, LaFleur BJ, et al. (2010) Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology 139:213–225 e213

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Van der Flier LG, Haegebarth A, Stange DE, Van de Wetering M, Clevers H (2009) OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137:15–17

    Article  PubMed  Google Scholar 

  7. Liu W, Liu Y, Zhu J, Wright E, Ding I, et al. (2008) Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin Cancer Res 14:1041–1049

    Article  CAS  PubMed  Google Scholar 

  8. Liu W, Chen L, Zhu J, Rodgers GP (2006) The glycoprotein hGC-1 binds to cadherin and lectins. Exp Cell Res 312:1785–1797

    Article  CAS  PubMed  Google Scholar 

  9. Zhang X, Huang Q, Yang Z, Li Y, Li C-Y (2004) GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res 64:2474–2481

    Article  CAS  PubMed  Google Scholar 

  10. Kobayashi D, Koshida S, Moriai R, Tsuji N, Watanabe N (2007) Olfactomedin 4 promotes S‐phase transition in proliferation of pancreatic cancer cells. Cancer Sci 98:334–340

    Article  CAS  PubMed  Google Scholar 

  11. Shinozaki S, Nakamura T, Iimura M, Kato Y, Iizuka B, et al. (2001) Upregulation of Reg 1α and GW112 in the epithelium of inflamed colonic mucosa. Gut 48:623–629

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Mannick E, Schurr J, Zapata A, Lentz J, Gastanaduy M, et al. (2004) Gene expression in gastric biopsies from patients infected with Helicobacter pylori. Scand J Gastroenterol 39:1192–1200

    Article  CAS  PubMed  Google Scholar 

  13. Oue N, Sentani K, Noguchi T, Ohara S, Sakamoto N, et al. (2009) Serum olfactomedin 4 (GW112, hGC‐1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 125:2383–2392

    Article  CAS  PubMed  Google Scholar 

  14. Liu W, Zhu J, Cao L, Rodgers G (2007) Expression of hGC‐1 is correlated with differentiation of gastric carcinoma. Histopathology 51:157–165

    Article  CAS  PubMed  Google Scholar 

  15. Aung P, Oue N, Mitani Y, Nakayama H, Yoshida K, et al. (2005) Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25:2546–2557

    Article  Google Scholar 

  16. Oue N, Aung PP, Mitani Y, Kuniyasu H, Nakayama H, et al. (2005) Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 69:17–22

    Article  CAS  PubMed  Google Scholar 

  17. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, et al. (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8:86–94

    Article  CAS  PubMed  Google Scholar 

  18. Yu L, He M, Yang Z, Chen G, Li M, et al. (2011) Olfactomedin 4 is a marker for progression of cervical neoplasia. Int J Gynecol Cancer 21:367–372

    Article  PubMed  Google Scholar 

  19. Chen L, Li H, Liu W, Zhu J, Zhao X, et al. (2011) Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. Carcinogenesis 32:986–994

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Koshida S, Kobayashi D, Moriai R, Tsuji N, Watanabe N (2007) Specific overexpression of OLFM4GW112/hGC−1 mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98:315–320

    Article  CAS  PubMed  Google Scholar 

  21. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474

    Article  PubMed  Google Scholar 

  22. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, et al. (2001) MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas. Cancer 92:1427–1434

    Article  CAS  PubMed  Google Scholar 

  23. Jang BG, Lee BL, Kim WH (2013) Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis. PLoS One 8: e82390.

  24. Grover PK, Hardingham JE, Cummins AG (2010) Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Rev 29:761–775

    Article  CAS  PubMed  Google Scholar 

  25. Oh H-K, Tan AL-K, Das K, Ooi C-H, Deng N-T, et al. (2011) Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17:2657–2667

    Article  CAS  PubMed  Google Scholar 

  26. Suh Y-S, Lee H-J, Jung E-J, Kim M-A, Nam KT, et al. (2012) The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol 19:1240–1249

    Article  PubMed  Google Scholar 

  27. Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, et al. (2011) The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8:511–524

    Article  PubMed  Google Scholar 

  28. Wentzensen N, Wilz B, Findeisen P, Wagner R, Dippold W, et al. (2004) Identification of differentially expressed genes in colorectal adenoma compared to normal tissue by suppression subtractive hybridization. Int J Oncol 24:987–994

    CAS  PubMed  Google Scholar 

  29. Li H, Rodriguez-Canales J, Liu W, Zhu J, Hanson JC, et al. (2013) Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. Am J Pathol 183:1329–1338

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Besson D, Pavageau A-H, Valo I, Bourreau A, Bélanger A, et al. (2011) A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics 10:M111 009712

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277).

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Pathology, Jeju National University Hospital, Ara-1-dong, Jeju, 690-767, Korea

    Bo Gun Jang

  2. Department of Pathology, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul, 110-799, Korea

    Woo Ho Kim

  3. Department of Anatomy, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul, 110-799, Korea

    Byung Lan Lee

Authors
  1. Bo Gun Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Byung Lan Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Woo Ho Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Woo Ho Kim.

Electronic supplementary material

Fig S1

(PPTX 6738 kb)

Fig S2

(PPTX 850 kb)

Fig S3

(PPTX 86 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jang, B.G., Lee, B.L. & Kim, W.H. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer. Virchows Arch 467, 285–294 (2015). https://doi.org/10.1007/s00428-015-1793-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-015-1793-9

Keywords

Search

Navigation